Cargando…

(18)F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy

OBJECTIVE: The aim of this study is to evaluate the diagnostic performance of FDG-PET/CT for the detection of residual disease after (chemo)radiotherapy in patients with head and neck squamous cell carcinoma (HNSCC) and to evaluate the prognostic value of the FDG-PET/CT findings. METHODS: Patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Helsen, Nils, Roothans, Dessie, Van Den Heuvel, Bert, Van den Wyngaert, Tim, Van den Weyngaert, Danielle, Carp, Laurens, Stroobants, Sigrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542639/ https://www.ncbi.nlm.nih.gov/pubmed/28771540 http://dx.doi.org/10.1371/journal.pone.0182350

Ejemplares similares

Quality Assessment in FDG-PET/CT Imaging of Head-and-Neck Cancer: One Home Run Is Better Than Two Doubles
por: Van den Wyngaert, Tim, et al.
Publicado: (2020)

Dual time point imaging in locally advanced head and neck cancer to assess residual nodal disease after chemoradiotherapy
por: Soffers, Frederik, et al.
Publicado: (2022)

Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [(18)F]HX4 PET imaging study in colorectal cancer xenografts
por: De Bruycker, Sven, et al.
Publicado: (2019)

Early Changes in [(18)F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts
por: Dockx, Yanina, et al.
Publicado: (2021)

RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison
por: Van Gestel, Dirk, et al.
Publicado: (2013)

Usefulness of Splenic Scintigraphy in Differentiating Splenosis and Malignancy on Gallium 68 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-NaI3-octreotide
por: Van Hecke, Stijn, et al.
Publicado: (2018)

Molecular Imaging of Apoptosis: The Case of Caspase-3 Radiotracers
por: Beroske, Lucas, et al.
Publicado: (2021)

How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research
por: De Bruycker, Sven, et al.
Publicado: (2018)

Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and (18)F-FDG-PET imaging
por: Ottoy, Julie, et al.
Publicado: (2019)

Precision Radiotherapy: (18)F-FDG PET-based radiotherapy planning in Head and Neck cancers
por: Subramanyam, Padma, et al.
Publicado: (2020)

A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck
por: Specenier, Pol M, et al.
Publicado: (2009)

Awake (18)F-FDG PET Imaging of Memantine-Induced Brain Activation and Test–Retest in Freely Running Mice
por: Miranda, Alan, et al.
Publicado: (2019)

Quantitative and clinical implications of the EARL2 versus EARL1 [(18)F]FDG PET-CT performance standards in head and neck squamous cell carcinoma
por: Cox, Maurice C., et al.
Publicado: (2023)

ADC Values of Cytologically Benign and Cytologically Malignant 18 F-FDG PET-Positive Lymph Nodes of Head and Neck Squamous Cell Carcinoma
por: de Koekkoek-Doll, Petra K., et al.
Publicado: (2022)

Is C‐11 Methionine PET an alternative to 18‐F FDG‐PET for identifying recurrent laryngeal cancer after radiotherapy?
por: Wedman, Jan, et al.
Publicado: (2018)

Dual time point based quantification of metabolic uptake rates in (18)F-FDG PET
por: den Hoff, Jörg van, et al.
Publicado: (2013)

Added value of (18)F-FDG-PET/CT and cardiac CTA in suspected transcatheter aortic valve endocarditis
por: Wahadat, Ali R., et al.
Publicado: (2019)

Head-to-Head Comparison of [(68) Ga]Ga-FAPI-46-PET/CT and [(18)F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer
por: Wegen, Simone, et al.
Publicado: (2022)

Correlation of [(18)F] FDG-PET/CT with dosimetry data: recurrence pattern after radiotherapy for head and neck carcinoma
por: Pisani, C., et al.
Publicado: (2021)

[(18)F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma
por: Vos, Joris L., et al.
Publicado: (2021)

Evaluation of the optimal combinations of modulation factor and pitch for Helical TomoTherapy plans made with TomoEdge using Pareto optimal fronts
por: De Kerf, Geert, et al.
Publicado: (2015)

Prevalence of osteoradionecrosis demonstrated in 18F-FDG PET-CT of post-high-dose-radiotherapy head and neck cancer patients
por: Sonoda, LI, et al.
Publicado: (2014)

Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update
por: Dewulf, Jonatan, et al.
Publicado: (2020)

Impact of combined (18)F-FDG PET/CT in head and neck tumours
por: Syed, R, et al.
Publicado: (2005)

Contribution of (18)F-FDG PET/CT to Staging of Head and Neck Malignancies
por: Ceylan, Yeşim, et al.
Publicado: (2018)

Asphericity derived from [(18)F]FDG PET as a new prognostic parameter in cervical cancer patients
por: Cegla, Paulina, et al.
Publicado: (2023)

(18)F‐FDG PET/CT for response evaluation of regional lymph nodes in 97 head and neck squamous cell carcinoma patients: Differences in the predictive value of residual disease after radiotherapy and chemoradiotherapy
por: Hanemaaijer, Saskia H., et al.
Publicado: (2020)

Incidental findings on 18-FDG PET–CT in head and neck cancer. A retrospective case-control study of incidental findings on 18-FDG PET–CT in patients with head and neck cancer
por: Casselden, Elizabeth, et al.
Publicado: (2018)

The diagnostic accuracy of (18)F-FDG PET/CT in diagnosing fracture-related infections
por: Lemans, Justin V. C., et al.
Publicado: (2018)

Assessment of the effect of therapy in a rat model of glioblastoma using [(18)F]FDG and [(18)F]FCho PET compared to contrast-enhanced MRI
por: Bolcaen, Julie, et al.
Publicado: (2021)

An exploration of under-registration of chronic kidney disease stages 3–5 in Belgian general practices using logistic regression
por: Van den Wyngaert, Ine, et al.
Publicado: (2022)

A dedicated paediatric [(18)F]FDG PET/CT dosage regimen
por: Cox, Christina P. W., et al.
Publicado: (2021)

FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma
por: Deantonio, Letizia, et al.
Publicado: (2008)

Prognostic value of FDG PET/CT during radiotherapy in head and neck cancer patients
por: Kim, Suzy, et al.
Publicado: (2018)

Longitudinal Characterization of [(18)F]-FDG and [(18)F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model
por: Waldron, Ann-Marie, et al.
Publicado: (2016)

Characterization of Structurally Diverse (18)F-Labeled d-TCO Derivatives as a PET Probe for Bioorthogonal Pretargeted Imaging
por: Adhikari, Karuna, et al.
Publicado: (2023)

Risk Stratification Using (18)F-FDG PET/CT and Artificial Neural Networks in Head and Neck Cancer Patients Undergoing Radiotherapy
por: Marschner, Sebastian N., et al.
Publicado: (2021)

Prognostic Value of Pretherapeutic Primary Tumor MTV from [(18)F]FDG PET in Radically Treated Cervical Cancer Patients
por: Cegla, Paulina, et al.
Publicado: (2021)

(18)F-FDG PET as novel imaging biomarker for disease progression after ablation therapy in colorectal liver metastases
por: Samim, M., et al.
Publicado: (2017)

Potential of (18)F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer
por: Choi, Noah C., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c9kumqbpeqf3srksqg49hiboa1